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Anthropometric factors and cutaneous melanoma: Prospective
data from the population-based Janus Cohort
Jo S Stenehjem 1, Marit B Veierød 2, Lill Tove Nilsen3, Reza Ghiasvand2, Bjørn Johnsen3, Tom K Grimsrud1,
Ronnie Babigumira1, Judith R Rees4,5 and Trude E Robsahm 1
1Department of Research, Cancer Registry of Norway, Oslo, Norway
2Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Oslo, Norway
3Norwegian Radiation Protection Authority, Østerås, Norway
4New Hampshire State Cancer Registry, Lebanon, NH
5Department of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH
The aim of the present study was to prospectively examine risk of cutaneous melanoma (CM) according to measured anthropo-
metric factors, adjusted for exposure to ultraviolet radiation (UVR), in a large population-based cohort in Norway. The Janus
Cohort, including 292,851 Norwegians recruited 1972–2003, was linked to the Cancer Registry of Norway and followed for CM
through 2014. Cox regression was used to estimate hazard ratios (HRs) of CM with 95% confidence intervals (CIs). Restricted
cubic splines were incorporated into the Cox models to assess possible non-linear relationships. All analyses were adjusted
for attained age, indicators of UVR exposure, education, and smoking status. During a mean follow-up of 27 years, 3,000
incident CM cases were identified. In men, CM risk was positively associated with body mass index, body surface area (BSA),
height and weight (all ptrends< 0.001), and the exposure-response curves indicated an exponential increase in risk for all
anthropometric factors. Weight loss of more than 2 kg in men was associated with a 53% lower risk (HR 0.47, 95% CI: 0.39,
0.57). In women, CM risk increased with increasing BSA (ptrend50.002) and height (ptrend<0.001). The shape of the height-
CM risk curve indicated an exponential increase. Our study suggests that large body size, in general, is a CM risk factor in
men, and is the first to report that weight loss may reduce the risk of CM among men.
The incidence rate of cutaneous melanoma (CM) has been
increasing steeply during the past three decades,1 and
presents a major burden in fair-skinned populations world-
wide.2 CM is the third most common cancer in Europe after
cancers of the colon/rectum and lung.3 Exposure to ultravio-
let radiation (UVR) is recognized as the most important risk
factor for CM.4 Further, pigmentation characteristics such as
nevi, hair and eye color, and the skin’s sensitivity to
sunburns, greatly modify an individual’s response to UVR
exposure.5
Anthropometric factors such as high body mass index
(BMI), large body surface area (BSA) and tall stature, have
all been associated with increased CM risk.6,7 In previous
population-based large cohort studies, higher CM risk has
been reported with increasing pre-diagnostic BSA and height
in both genders,7,8 while for BMI a positive association has
only been observed in men.7,9 The major strengths of these
studies were the large numbers of incident CM cases and the
pre-diagnostic measurement of height and weight. Other
cohort studies investigated CM risk in both genders with
respect to self-reported height and weight at baseline, and
did not detect an association with BMI after adjustment for
sun exposure and phenotype.10,11
Mixed evidence has been provided on the associations
between anthropometric factors and CM risk in case-control
studies that relied on self-reported height and weight, but
had detailed information on UVR exposure and pigmentation
characteristics. Two studies have reported a positive associa-
tion between BMI and CM risk in men,12,13 whereas another
study found no such association.14 A pooled analysis of eight
case-control studies in women found a positive association
between CM risk and height and weight, but did not detect
any associations with BMI or BSA.15 The most recent meta-
analysis of obesity and CM risk found a moderate positive
association between BMI and CM risk in men, but no associ-
ation in women.16 The pooled effect estimates were similar
for overweight and obese men, and the authors highlighted
the need for further investigation with non-linear models to
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assess the shape of the exposure-response curve for BMI and
CM risk. The lack of an association in women has been
attributed to uncontrolled confounding by differences in sun
seeking behavior between normal weight and obese
women16,17; this underscores the importance of adjustment
for behavioral factors such as sunburns, sunbathing and
solarium use.
The overall aim of the present study was to prospectively
examine CM risk adjusted for UVR indicators, according to
measured BMI, BSA, height, weight and weight change, in a
large population-based cohort of Norwegian men and
women. Further, we aimed to assess possible non-linear rela-
tionships between these anthropometric factors and CM risk,
and to assess CM risk by anatomical site and by histological
subtype.
Methods
Study population and study design
The Janus Serum Bank Cohort (hereafter termed the Janus
Cohort) is a population-based biobank for prospective cancer
studies containing serum samples and data from health
examinations, including measured anthropometry and ques-
tionnaire data from 292,851 Norwegians who participated in
the following five surveys between 1972 and 2003. Detailed
descriptions of the Janus Cohort, its data and establishment,
have been published previously.18
1. The Oslo Study I, invited men aged 20–49 residing in Oslo
aged 20–49 years during 1972–1973.
2. The Norwegian Counties Study was a three-wave survey
(1974–1978, 1977–1983 and 1985–1988), inviting men and
women aged 20–49 years residing in the counties Finn-
mark, Oppland and Sogn og Fjordane.
3. The Oslo Age 40 Program invited men and women aged
40 residing in Oslo during 1981–1999.
4. The National Age 40 Program triennially invited all men
and women aged 40–42 years in all Norwegian counties
during 1985–1999.
5. The TROFINN Health Study invited all men and women
aged 30–75 years residing in the counties Troms and Finn-
mark during 2001–2003.
The present study is based on a comprehensive research
file created through linkage of measured anthropometric and
questionnaire data from the Janus Cohort to individual
information on education, occupation, cancer diagnoses, vital
status and cause of death, and to group level information on
ambient UVR data and sun tanning habits. Details of the
data sources and linkages are available in the published study
protocol.19
Legal and ethical approvals were obtained from the
Norwegian Data Inspectorate, the Regional Committee for
Medical Research Ethics, and the Norwegian Directorate of
Health.
Assessment of exposures
In the Janus Cohort, baseline measurements of height (to the
nearest 1 cm) and weight (to the nearest 0.5 kg) were
obtained by trained staff according to a standardized proto-
col. BMI was calculated as kg/m2; BSA (m2) was calculated
using the DuBois and DuBois’ equation (weight0.4253 3
height0.7253 3 0.007184)20; and weight change was calculated
by subtracting the 1985–88 weight measure from the 1974–
78 measure (median time between the weight measurements
was 10 years). BSA, height and weight were categorized
according to sex-specific quintiles, and BMI according to the
World Health Organization’s (WHO) BMI classification
using the additional cut-points for normal range and over-
weight as recommended by the WHO Expert Consultation:
underweight (<18.5 kg/m2), normal weight 1 (18.5–22.9 kg/
m2), normal weight 2 (23.0–24.9 kg/m2), overweight 1 (25.0–
27.4 kg/m2), overweight 2 (27.5–29.9 kg/m2) and obese
(30.0 kg/m2).21 Weight change was categorized as <–
2.0 kg, 22.0 to 2.0 kg, and >2.0 kg. The questions about
smoking and physical activity were worded differently in
each survey and were harmonized into the following catego-
ries for physical activity: inactive, low, medium, high,
unknown; and for smoking status: current, former, never,
unknown (see Supporting Information Material for physical
activity and Hjerkind et al.18 for smoking).
Occupation at baseline (indoor, mixed, outdoor, unknown)
and highest attained educational level at baseline (none, com-
pulsory, upper secondary, college/university, unknown) were
obtained by linkage to Statistics Norway using the 11-digit per-
sonal identification number (PIN) assigned to Norwegian citi-
zens. The categorization of occupation followed Alfonso et al.22
who used these categories as proxies for occupational sun
exposure.
Ambient UVR exposure was based on region-specific
cumulated doses of ultraviolet-B (UVB) radiation between
1972 and 1991 (when 97.5% of the Janus Cohort was
What’s new?
Anthropometric factors, such as height and weight, affect melanoma risk, according to new results. These authors looked at
data from a large Norwegian cohort, including 3000 cases of cutaneous melanoma. They found that body mass index, body
surface area, weight, and height all influence CM risk in males, with an exponential increase for all factors. In women, only
height and body surface area correlated with cancer risk – possibly because women with higher weight and BMI sunbathe
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recruited), derived from reconstructed measurements and
modelled values as described by Medhaug et al.23 UVR expo-
sure estimates were then linked to region of residence at
baseline. Cumulative UVB doses were categorized as north,
mid, southwest, southeast inland, southeast coast; decreasing
doses were seen from north to south.
Data on the annual mean number of sunburns, sunbath-
ing vacations, and solarium sessions (women only) from the
Norwegian Women and Cancer study (NOWAC),19,24 were
linked to the Janus Cohort on a group-level, based on combi-
nations of age, county and time period. The rationale for
conducting this group-level data linkage between the
NOWAC (women only) and the Janus Cohort (men and
women) was based on a survey conducted by the Norwegian
Cancer Society,25 showing only small gender differences for
sunburns and sunbathing vacations, and that the solarium
was more frequently used by women than men.
Identification of cancer cases
Using PINs, the Janus Cohort was linked to the Cancer Reg-
istry of Norway (CRN) to provide a complete cancer history
(1953–2014) in all individuals with a CM diagnosis. Linkage
to the Norwegian National Population Register provided data
on vital status, year of death, and year of emigration. Report-
ing of incident cancers to the Cancer Registry is compulsory
in Norway, and data from several sources ensure high quality
data.26,27
Cases were required to be (i) histologically verified as CM,
(ii) to have no cancer prior to their CM diagnosis and (iii) to
occur after start of follow-up. Cases occurring before start of
follow-up (n5 447) or during the weight change period
(n5 50) were excluded. Information on skin cancer
localization was based on a local CRN modified version of
the International Classification of Diseases, 7th revision (ICD-
7 codes 1900–1909), converted into ICD-10 codes (head and
neck5C43.0–4; trunk5C43.5; upper limbs5C43.6; lower
limbs5C43.7; not otherwise specified5C43.9). Subtypes of
CM were defined by using histology codes from ICD-Oncology,
3rd edition (superficial spreading melanoma5 8743; nodular
melanoma5 8721; other5 8000, 8723, 8730, 8742, 8744, 8745,
8770, 8772; not otherwise specified5 8720).
Study samples and follow-up
From the full Janus Cohort (n5 292,851), we excluded 1,249
individuals, leaving 291,602 individuals available for analysis
of CM risk in relation to BMI, BSA, weight and height (Fig.
1). CM risk according to weight change was examined in a
subsample of 37,262 individuals with repeated anthropomet-
ric measurements (Fig. 1).
For the full cohort, start of follow-up (baseline) was
defined as the year of first participation in the Janus Cohort
between 1972 and 2003. For the subsample with repeated
measurements (n5 37,262), baseline was defined as the year
of the second weight measurement conducted between 1985
and 1988. End of follow-up was December 31, 2014.
Data analysis
To examine the relationship between the anthropometric fac-
tors and CM risk, Cox regression was used to estimate haz-
ard ratios (HRs) with 95% confidence intervals (CIs). Entry
time was age at baseline, and exit time was age at CM diag-
nosis, emigration, death, or end of follow-up, whichever
occurred first. To account for group level data (ambient
UVR, sunburns and solarium use), standard errors that allow
for intragroup correlation were used (cluster option in the
specification of the variance-covariance matrix in Stata).28
Age was used as the time scale with entry at age at start of
follow-up. To check for cohort effects, we also ran Cox
regression stratified by 10 year birth cohorts. The multivari-
able models were adjusted for attained age (as the time scale),
BMI, height, ambient UVR of residence, average intensity of
sunburns, occupation, physical activity, education and smok-
ing status (specified in each result table). In women, the mul-
tivariable models were additionally adjusted for the average
intensity of solarium sessions. In an initial model, the average
intensity of sunbathing vacations was also included to check
whether this improved the adjustment provided by UVR
exposure indicators.
Tests of interactions between sex and anthropometric fac-
tors were carried out by including a product term in each
regression model. To check whether BMI at first measure-
ment altered the effect of weight change on CM risk, we
tested for interaction by including a product term of weight
change and BMI at first measurement. In these analyses, BMI
was categorized as <27.5/27.5 kg/m2 in men and <25/
25 kg/m2 in women, as women are likely to have a higher
percentage of body fat than men at equal BMI.29
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Restricted cubic splines were incorporated into the Cox
models to assess the shape of the exposure-CM risk relation-
ships using the Stata commands -rcsgen- and -partpred-.30,31
Population attributable fractions (PAFs) of CM associated
with BMI, BSA, height and weight were estimated by the
-punafcc- command in Stata.32
Tests for linear trend across categories were performed by
entering ordinal variables as continuous in the regression mod-
els. The proportional-hazards assumption was evaluated by
Schoenfeld residuals and log–log plots. Tests for significance
were two-sided, and p-values of <0.05 were considered to rep-
resent statistical significance. All data analyses were performed
using Stata version 14.2 (StataCorp, College Station, TX).
Results
During an average follow-up of 27 years (range <1–43
years), 3,000 first primary CM cases were identified in the
Janus Cohort. Average year of birth was 1942 (range 1900–
1976) in men and 1944 (range 1900–1976) in women. Aver-
age age at baseline was 42 years (range 15–89 years) and age
at diagnosis was 69 (range men 20–102; women 20–101) in
both sexes (Table 1). In men, 59% of the CMs were located
on the trunk, while in women the most common location
was the lower limbs (Supporting Information Table S1).
We found statistically significant interaction terms
between sex and anthropometric factors (results not shown),
and all results are therefore shown stratified by sex. Table 2
shows risk of CM according to BMI, BSA, height and weight,
by sex. In men, CM risk increased significantly with increas-
ing levels of BMI, BSA, height and weight (ptrends< 0.001). In
both sexes, positive significant associations were seen for
BSA, although the strongest effect was seen in men with a
58% increase in CM risk for Quintile 5 compared to Quintile
1. We also found significant positive associations for height,
with over 50% increased CM risk for Quintile 5 compared to
Quintile 1 in both sexes. Among women, no associations
were found for BMI and weight in relation to CM risk.
The associations between CM risk and anthropometric
factors were also assessed using restricted cubic splines. In
men (Fig. 2a), the HR showed a slight exponential increase
according to BMI (reference 23 kg/m2, HR5 1.00). For BSA
(reference 1.85 m2), the HRs increased exponentially with
statistical significance until a BSA of around 2.65 m2. For
height (reference 172 cm), CM risk increased with statistical
significance until a height of 195 cm, and then declined. For
weight (reference 70 kg), CM risk showed a slight exponen-
tial increase with statistical significance until 115 kg. In
women (Fig. 2b), CM risk according to BMI increased
towards the null at 23 kg/m2, and then declined. For BSA,
the CM risk increased exponentially from the null at
1.60 m2, plateaued around 1.80 m2 and then remained statis-
tically significant until 2.00 m2. CM risk according to height
increased exponentially with statistical significance from
around 170 to 180 cm, and then declined. CM risk according
to weight decreased slightly with increasing weight, although
this was not statistically significant.
Table 3 shows CM risk according to weight change in a
subsample of the Janus Cohort. In men, a weight loss of
>2 kg was associated with a 53% decrease in CM risk (HR
0.47, 95% CI: 0.39, 0.57). In women, neither weight gain nor
weight loss was associated CM risk. No significant interaction
was found between weight change and BMI at first measure-
ment (men: pinteraction5 0.295; women: pinteraction5 0.054).
The weight change study sample (n5 37,262) differed from
the rest of the cohort (n5 254,340) in that it was one of the
earliest surveys in the Janus Cohort. Persons in the weight
change sample were born earlier, were younger at baseline
and older at diagnosis, and were shorter and lighter weight at
baseline (Supporting Information Table S2).
Table 4 shows PAFs of CM associated with BMI, BSA,
height and weight. In men, a BMI >25 kg/m2 was estimated
to account for 2% of the CM cases, while in women no sta-
tistically significant PAF was found. BSA above the median
was estimated to account for 14 and 8% of the male and the
female CM cases, respectively. Height above the median was
estimated to account for 10% of the male and 6% of the
female CM cases, respectively. Weight above the median was
estimated to account for 7% of the male CM cases, while in
women no statistically significant PAF was found.
We also examined CM risk according to anthropometric
factors by anatomical site and histological subtype (Support-
ing Information Material). In men (results not shown in
table), significant positive trends were found for trunk CMs
according to all anthropometric factors, and head and neck
CMs according to height (ptrends < 0.001). In women (Sup-
porting Information Table S3), significant positive trends
were found for all anthropometric factors in relation to CM
of the upper limbs (ptrends 0.001–0.028). For lower limb
CMs, significant positive trends were seen for BSA and height
(ptrends 0.046 and <0.001, respectively). Women with BMI
27.5–29.9 kg/m2 had an 83% increased risk of upper limb
CM compared to those with BMI 18.5–22.9 kg/m2.
For CM risk by histological subtype in men (results not
shown in table), significant dose-related risks were found for
superficial spreading melanoma (ptrends  0.001–0.011) and
nodular melanoma (ptrends  0.001–0.002) according to all
the anthropometric factors. In women, dose-related risks of
superficially spreading melanoma and nodular melanoma
were seen for BSA (ptrends 0.004 and 0.010, respectively) and
height (ptrends <0.001 and 0.003, respectively).
Models including stratification on 10-year birth cohorts
were also tested, but the results did not change materially
(not shown). In an initial model, the average intensity of
sunbathing vacations and sunburns were included in the
same model, but no effect was seen from sunbathing vaca-
tions (results not shown) and it was hence not included in
the final models.
Discussion
This study prospectively examined risk of CM according to
pre-diagnostic BMI, BSA, height, weight and weight change
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Table 1. Characteristics of the study population
Men Women
Participants, n (%) 152,012 (52) 139,590 (48)
Year of birth, mean (range) 1942 (1900–1976) 1944 (1900–1976)
Age at baseline, mean years (range) 42 (15–89) 42 (15–89)
Years of follow-up, mean (range) 27 (<1–43) 27 (<1–41)
Age at diagnosis, mean (range) 69 (20–102) 69 (23–101)
BMI, mean kg/m2 (SD)1 25.2 (3.1) 24.2 (4.0)
BSA, mean m2 (SD)1 1.98 (0.15) 1.72 (0.14)
Height, mean cm (SD)1 177.7 (6.7) 164.8 (6.1)
Weight, mean kg (SD)1 79.6 (11.3) 65.7 (11.2)
Weight change, mean kg (SD)2 3.0 (5.6) 3.2 (6.0)
Ambient UVR of residence, n (%)
North 21,556 (14) 21,118 (15)
Mid 18,841 (13) 19,875 (14)
Southwest 21,148 (14) 21,048 (15)
Southeast inland 67,198 (44) 52,401 (38)
Southeast coast 23,269 (15) 25,148 (18)
Sunburns, mean (SD)3 0.88 (0.13) 0.88 (0.14)
Sunbathing vacations, mean (SD)3 1.21 (0.36) 1.17 (0.34)
Solarium sessions, mean (SD)3 NA 1.05 (0.52)
Occupation, n (%)
Indoor 81,230 (54) 89,793 (64)
Mixed 50,491 (33) 30,196 (22)
Outdoor 18,185 (12) 5,037 (4)
Unknown 2,106 (1) 14,564 (10)
Physical activity, n (%)
Inactive 29,721 (19) 28,764 (20)
Low 79,539 (52) 95,301 (68)
Medium 37,516 (25) 13,855 (10)
High 4,349 (3) 710 (1)
Unknown 887 (1) 960 (1)
Smoking status, n (%)
Never 68,578 (45) 55,456 (40)
Former 40,381 (27) 25,246 (18)
Current 40,134 (26) 55,199 (39)
Unknown 2,919 (2) 3,689 (3)
Education, n (%)
None 512 (0.3) 458 (0.3)
Compulsory 45,896 (30.2) 46,823 (33.5)
Upper secondary 74,466 (49.0) 69,584 (49.9)
College/university 30,539 (20.1) 22,268 (16.0)
Unknown 599 (0.4) 457 (0.3)
Abbreviations: BMI: body mass index; BSA: body surface area; NA: not applicable, SD: standard deviation; UVR: ultraviolet radiation.
1Missing: BMI and BSA (n5717); height (n5576); weight (n5 695).
2Weight change only available in a subsample with repeated measurements (n537,262).
3Group-level data (age-, county- and time period-specific) on average intensity of yearly sunburns, sunbathing vacations and solarium use (women
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women, with 3,000 incident CM cases occurring during an
average follow-up of >26 years. In men, we found dose-
related increases in CM risk for all anthropometric factors,
and confirmed that weight loss was associated with a
decreased CM risk. In women, CM risk increased signifi-
cantly with increasing BSA and height.
The positive association between BMI and CM risk seen
in men is consistent with other large population-based cohort
studies using pre-diagnostic measurements of height and
weight.7,9 smaller Danish cohort study with 188 male CM
cases found no statistically significant association, although
CM risk increased with increasing BMI.33 Another cohort
study, relying on self-reported height and weight, could not
detect a BMI–CM risk association in men.11 Our finding of
no association between BMI and overall CM risk (all ana-
tomical sites combined) in female participants corresponds
Table 2. Hazard ratios (HRs) and 95% confidence intervals (CIs) of cutaneous melanoma according to body mass index, body surface area,
height and weight in 291,602 Norwegian men and women in the Janus Cohort
Men Women
Exposure C HR1 HR2 (95% CI) ptrend
3 C HR1 HR2,4 (95% CI) ptrend
3
Body mass index (kg/m2)4
Continuous (per 5) 1.08 1.15 (1.08,1.22) <0.001 0.95 1.00 (0.93, 1.07) 0.892
<18.5 3 0.51 0.56 (0.16, 1.95) 20 0.78 0.85 (0.56, 1.30)
18.5–22.9 357 1.00 1.00 (reference) 567 1.00 1.00 (reference)
23.0–24.9 508 1.21 1.21 (1.07, 1.38) 323 1.06 1.10 (0.98, 1.25)
25.0–27.4 495 1.17 1.21 (1.08, 1.35) 208 0.93 0.99 (0.88, 1.11)
27.5–29.9 215 1.17 1.29 (1.13, 1.48) 100 0.90 1.00 (0.83, 1.20)
30.0 101 1.11 1.26 (1.01, 1.57) 92 0.83 0.95 (0.76, 1.17)
Body surface area (m2)
Continuous (per 0.05) 1.08 1.06 (1.05, 1.07) <0.001 1.04 1.03 (1.01, 1.05) 0.002
Q1 (M: 1.09–1.85; W: 0.78–1.60) 249 1.00 1.00 (reference) 216 1.00 1.00 (reference)
Q2 (M: 1.85–1.93; W: 1.61–1.68) 305 1.25 1.12 (0.96, 1.29) 242 1.12 1.04 (0.91, 1.18)
Q3 (M: 1.93–2.00; W: 1.69–1.75) 345 1.44 1.25 (1.10, 1.42) 262 1.23 1.11 (0.91, 1.35)
Q4 (M: 2.01–2.10; W: 1.76–1.83) 370 1.61 1.36 (1.21, 1.52) 309 1.46 1.30 (1.12, 1.52)
Q5 (M: 2.11–2.95; W: 1.84–2.72) 410 1.90 1.58 (1.41, 1.78) 281 1.37 1.22 (1.01, 1.47)
Height (cm)5
Continuous (per 5) 1.21 1.13 (1.09, 1.17) <0.001 1.20 1.18 (1.07, 1.17) <0.001
Q1 (M: 124–172; W: 100–160) 261 1.00 1.00 (reference) 232 1.00 1.00 (reference)
Q2 (M: 173–176; W: 161–163) 310 1.18 1.04 (0.90, 1.21) 232 1.42 1.28 (1.12, 1.47)
Q3 (M: 177–179; W: 164–166) 308 1.46 1.24 (1.01, 1.52) 263 1.42 1.23 (1.06, 1.43)
Q4 (M: 180–183; W: 167–170) 377 1.57 1.27 (1.09, 1.49) 302 1.50 1.25 (1.05, 1.48)
Q5 (M: 184–210; W: 171–195) 423 2.01 1.55 (1.36, 1.77) 282 1.93 1.52 (1.31, 1.76)
Weight (kg)4
Continuous (per 5) 1.08 1.04 (1.02, 1.07) <0.001 1.02 1.00 (0.97, 1.03) 0.993
Q1 (M: 33–70; W: 24–57) 263 1.00 1.00 (reference) 236 1.00 1.00 (reference)
Q2 (M: 71–76; W: 58–61) 329 1.16 1.00 (0.81, 1.24) 252 1.25 1.12 (0.89, 1.43)
Q3 (M: 77–81; W: 62–66) 341 1.41 1.16 (0.98, 1.38) 278 1.23 1.07 (0.89, 1.27)
Q4 (M: 82–88; W: 67–74) 386 1.54 1.22 (1.06, 1.40) 286 1.35 1.14 (0.94, 1.38)
Q5 (M: 89–182; W: 75–173) 360 1.59 1.24 (1.05, 1.47) 258 1.26 1.08 (0.87, 1.33)
Abbreviations: C: cases; M: men; Q: quintile; W: women.
Missing: weight (n5695); height (n5576); body mass index and body surface area (n5717).
1Adjusted for age (as the time scale).
2Adjusted for age (as the time scale), ambient UVR of residence, average intensity of sunburns, occupation, physical activity, education, smoking
status.
3Modeled as a continuous variable to test for linear trend.
Additionally adjusted for average intensity of solarium sessions.
4Adjusted for height in addition to covariates in 2 and 4.
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with previous cohort studies,7,11,33 and with a pooled analysis
based on eight case-control studies.15 However, when looking
at upper limb CM risk in females, we also found significant
associations for BMI (ptrend 0.028) and weight (ptrend 0.019);
this suggests that confounding by differences in sun seeking
behavior between normal weight and obese women is
Figure 2. (a) Men: Restricted cubic splines displaying hazard ratios of CM risk with 95% confidence intervals according to anthropometric
factors in men, adjusted for age (as the time scale), ambient UVR of residence, average intensity of sunburns, occupation, physical activity,
education and smoking status. (b) Women: Restricted cubic splines displaying hazard ratios of CM risk with 95% confidence intervals
according to anthropometric factors in women, adjusted for age (as the time scale), ambient UVR of residence, average intensity of sun-
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restricted to anatomical sites more often covered by clothing.
Confounding by sun seeking behavior may thus be the main
reason for the differences in CM risk seen between men and
women in our data.
The latest meta-analysis on anthropometric factors and
CM risk found similar risk estimates for BMI 25–30 kg/m2
and BMI 30 kg/m2,16 and highlighted the need for an
assessment of a possible non-linear relationship in future
studies, which to our knowledge has not been conducted pre-
viously. Consistent with this suspected underlying plateau in
risk estimates, our spline-models revealed that CM risk
increased and then levelled off with increasing BMI in men,
and identified a twofold increased risk in men with a BSA of
>2.60 m2. The exponential increase in CM risk according to
BSA found in our female participants corresponds well with
the findings from two other Nordic cohorts,7,34 and with the
50% increased risk reported in the meta-analysis.16 As
pointed out by Dennis et al.10 BSA is a measure of body sur-
face that potentially can receive UVR exposure and it is a
proxy of the number of skin cells able to convert to cancer
cells and not necessarily a measure of obesity in relation to
CM risk. Our analyses of BSA showed increased risk of CM
in both sexes, which is in agreement with an effect both from
obesity and UVR dose.
To our knowledge, this is the first study to report CM
risk in relation to weight change in men. Interestingly, a 53%
lower CM risk was seen with a weight loss of >2 kg over a
median time period of 10 years. This suggests that weight
loss interventions may be an effective means of reducing CM
risk in men. In women, however, we did not find any associ-
ation between weight change and CM risk. Hormone use
may be a potential cofounding factor, which we were unable
to consider in our analyses. A recent study, found that pro-
gestins reduced CM risk, while estrogens increased CM
risk.35 If hormone use explains our results for weight change
in women, the proportion of progestin users should be larger
among those who gain weight than those who lose weight.
Moreover, the risk-reducing effect of progestin should also be
stronger than the risk-increasing effect of estrogens. However,
this remains unclear and should be further examined in a
dataset with individual data on hormone use.
Biologic mechanisms that might explain the effect of obe-
sity and weight change seen in our data include the release
and function of insulin and leptin, which are both linked to
a positive energy balance.36 Obesity-induced chronic activa-
tion of insulin enhances the milieu for oncogenic transforma-
tion by driving cell growth and proliferation, and by
inhibiting apoptosis.36,37 Leptin is released by adipose tissue
and plays an important role in the regulation of insulin sensi-
tivity and body weight.38,39 Increased diagnostic serum levels
of leptin have been associated with increased CM risk, possi-
bly caused by a leptin-induced increase in neoangiogenesis,
reduction in melanogenesis and decrease in the melanocytes’
capacity of DNA repair.40,41
Table 3. Hazard ratios (HRs) and 95% confidence intervals (CIs) of cutaneous melanoma according to weight change in a subsample of
37,262 Norwegian men and women in the Janus Cohort
Men (n518,332) Women (n518,930)
Weight change (kg) C HR1 HR2 (95% CI) C HR1 HR2,3 (95% CI)
<–2.0 10 0.45 0.47 (0.39, 0.57) 21 1.01 1.09 (0.70, 1.68)
22.0 to 2.0 61 1.00 1.00 (reference) 48 1.00 1.00 (reference)
>2.0 101 1.07 1.10 (0.84, 1.44) 80 0.92 0.95 (0.59, 1.53)
Abbreviations: C: cases; CI: confidence interval; HR: hazard ratio.
1Adjusted for age (as the time scale).
2Adjusted for age (as the time scale), height, ambient UVR of residence, average intensity of sunburns, occupation, physical activity, education,
smoking status.
3Additionally adjusted for average intensity of solarium sessions.
Table 4. Population attributable fractions (PAFs) and 95% confidence intervals (95% CIs) of cutaneous melanoma associated with anthropometric
factors
Men Women
Exposure PAF1 (95% CI) PAF1,2 (95% CI)
BMI3 >25.0 kg/m2 0.02 (0.002, 0.04) 20.02 (–0.05, 0.02)
BSA >median (men >1.97 m2; women >1.71 m2) 0.14 (0.10, 0.17) 0.08 (0.04, 0.13)
Height4 >median (men >178 cm; women >165 cm) 0.10 (0.06, 0.14) 0.06 (0.01, 0.11)
Weight3 >median (men >79 kg; women >64 kg) 0.07 (0.02, 0.10) 0.03 (–0.02, 0.08)
Abbreviations: BMI: body mass index; BSA: body surface area.
1Adjusted for age (as the time scale), ambient UVR of residence, average intensity of sunburns, occupation, physical activity, education, smoking
status.
2Additionally adjusted for average intensity of solarium sessions.
3Adjusted for height in addition to covariates in 1 and 2.
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The dose-response relations between height and CM risk
seen in our data for both men and women are similar to
those reported by others.7,42,43 However, we found distinct
differences between the sexes with respect to anatomical site.
In men, the clearest associations with height were found for
head, neck and trunk CMs, while in women dose-response
relations with height were only seen for CMs located on the
limbs. The latter finding differs from the pooled analysis by
Olsen et al.15 who found no differences in risk according to
height across anatomical sites in women. Also, the shape of
the height-CM risk curve (all anatomical sites combined) dif-
fered. In men, the curve increased towards 190 cm, plateaued
and then declined for the tallest individuals (200–210 cm),
whereas in women the risk increased towards the 180 cm
and then declined.
Several underlying mechanisms have been suggested to
explain the association between height and CM risk. One
hypothesis is simply that height is a proxy of the number of
cells in the body that may develop into neoplasms.44 Our results
were fairly similar for height and BSA, and thereby support the
hypothesis that a larger number of melanocytes increases the
risk of CM. Another possible explanation is that tall stature as
an adult is an indicator of nutritional status during childhood,
and that energy excess may activate obesity-related mechanisms
(i.e., cell proliferation, inhibition of apoptosis and angiogene-
sis).45 Moreover, early life caloric restriction has been shown to
have a lasting influence on the prevalence of neoplasms in
rats.46 A role for the endocrine system has also been suggested,
as height has been associated with circulating levels of insulin-
like growth factor binding protein 3 (IGFBP-3).47 As pointed
out by Kabat et al.48 80% of the variation in height in Western
populations has been ascribed to genetics and at least 180 loci
have been found to influence adult height.49 However, it is
unclear whether genetics may also be a shared etiologic factor
for both height and CM risk.
Although it has been estimated that over 85% of the CM
cases may be attributed to UVR exposure (based on UK
data),4 we find it interesting from a public health perspective
that 7% of our male CM cases could be ascribed to weight
>79 kg, and that 14% and 8% of the CM cases could be
ascribed to BSA above 1.97 m2 and 1.71 m2 in men and
women, respectively. As with various other cancer forms,
these findings indicate that reduction in body weight may
also play a role for reduction in CM risk, at least in males.
However, it is important to bear in mind that PAFs of CM
estimated for different exposures may not add up to 100%, as
the estimation will depend on the exposure assessment.
Strengths of our study include the prospective design and
long follow-up period; the inclusion of 3000 first primary
CM cases from a population-based cancer registry based on
compulsory reporting of incident cancers; and the pre-
diagnostic measurements of height and weight performed by
trained personnel according to a standardized protocol. In
this setting, pre-diagnostic measurements of height and
weight are considerably more reliable than self-reports50;
Self-reported height and weight are likely to be over- and
underreported, respectively, which in turn would lead to
under- and overestimations of risk.29
An important limitation of this study is the lack of indi-
vidual information on sun tanning habits. We accounted for
some of the variation in sunburns and solarium sessions by
using group level data (specific to age, period, and county of
residence), but residual confounding cannot be excluded.
Confounding may explain the results in women as we found
no association between BMI or weight and CM risk in ana-
tomical sites usually covered by clothing. The exposure-CM
risk curves suggested a decline in risk with increasing BMI
and weight, possibly caused by differences in sun tanning
habits between normal weight and obese women. Still, adjust-
ment for regional measures of ambient UVR, and for indoor/
outdoor occupation and physical activity, seemed to capture
a fair amount of the variation as the CM risk estimates were
significantly associated with increasing values of these UVR
indicators (results not shown). Information on phenotype
and nevi, which are known CM risk factors,5 were not avail-
able and may have resulted in residual confounding if they
were disproportionately distributed across anthropometric fac-
tors. Moreover, we did not have information on hormone use,
and were hence unable to adjust for the potential confounding
effect of progestin, which was recently found to reduce CM
risk.35 The weight change study sample (n5 37,262), based on
the Norwegian Counties Study, differed from that of the
remaining full cohort sample (n5 254,340) in several aspects
(i.e., year of birth, age at baseline, age at diagnosis, and height
and weight at baseline). However, the Norwegian Counties
Study included the counties Finnmark, Sogn og Fjordane and
Oppland, located in northern, western and southeastern Nor-
way, respectively, and represented the diversity in population
density and sources of income at the time.51
In summary, this large population-based cohort provided
evidence that BMI, BSA, height and weight are positively
associated with CM risk in males. Our study also provides
new insights into the shape of the exposure-risk curves, and
indicates an exponential increase in CM risk for all anthropo-
metric factors in males. This study is the first to report that
men may benefit from weight loss in order to decrease their
CM risk. In women, dose-response associations for CM risk
were found with BSA and height. Further, by inspection of
the BMI-CM risk curve in women, we found indications of
confounding by sun tanning habits, which in turn warrants
further study with meticulous UVR adjustment by use of
individual and repeated UVR exposure data for an assess-
ment of possible time-dependent effects.
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